Cite
HARVARD Citation
Velcheti, V. et al. (n.d.). Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer. Journal for immunotherapy of cancer. p. . [Online].